Visicol and Levaquin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Visicol (sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate) and Levaquin (levofloxacin). Common drug interactions include peripheral vascular disorder among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Visicol and Levaquin. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Visicol?

Visicol has active ingredients of sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate. eHealthMe is studying from 471 Visicol users. Check the latest studies of Visicol.

What is Levaquin?

Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. eHealthMe is studying from 56,638 Levaquin users. Check the latest studies of Levaquin.



On Aug, 03, 2026

23 people who take Visicol and Levaquin together, and have interactions are studied.

Visicol and Levaquin drug interactions.

What are the common drug interactions of Visicol and Levaquin, by gender? *:

female:

  1. Peripheral vascular disorder
  2. Chronic kidney disease
  3. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
  4. Acute left ventricular failure (heart attack)
  5. Acute respiratory failure
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Depression
  8. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  9. Hyperlipidaemia (presence of excess lipids in the blood)
  10. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

male:

  1. Abdominal pain
  2. Asthenia (weakness)
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Anaemia (lack of blood)
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  7. Balance disorder
  8. Bone disorder
  9. Breast mass
  10. Calculus ureteric (stone in ureter)

What are the common drug interactions of Visicol and Levaquin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Implant site pain
  2. Oedema peripheral (superficial swelling)
  3. Shoulder pain
  4. Syncope (loss of consciousness with an inability to maintain postural tone)
  5. Ventricular dysfunction (heart dysfunction)
  6. Ventricular fibrillation (abnormally irregular heart rhythm)
  7. Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)
  8. Pacemaker complication
  9. Blood cholesterol increased
  10. Chest pain

60+:

  1. Abdominal pain
  2. Asthenia (weakness)
  3. Anaemia (lack of blood)
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  6. Balance disorder
  7. Bone disorder
  8. Breast mass
  9. Calculus ureteric (stone in ureter)
  10. Cellulitis (infection under the skin)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 6 people, 26.09%
  2. Back Pain: 3 people, 13.04%
  3. Stress And Anxiety: 2 people, 8.70%
  4. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 8.70%
  5. High Blood Cholesterol: 2 people, 8.70%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 8.70%
  7. Depression: 2 people, 8.70%
  8. Bone Disorder: 2 people, 8.70%
  9. Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Visicol and Levaquin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Visicol and Levaquin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Visicol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Levaquin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Visicol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levaquin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate and levofloxacin (the active ingredients of Visicol and Levaquin, respectively), and Visicol and Levaquin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: